Biosimilars Litigation and Client Counseling
April 24, 2025
By: Aziz Burgy, Ricardo Camposanto, Darpan R. Singh
American Bar Association Section of Intellectual Property Law
Axinn partner Aziz Burgy and associates Ricardo Camposanto and Darpan Singh co-authored a chapter in the ABA Section of Intellectual Property Law publication, Biosimilars Litigation and Client Counseling.
Biosimilars Litigation and Client Counseling is a guide to the field of biologic products and biosimilars, as well as the laws governing them, most notably the Biologics Price Competition and Innovation Act.
Click here to access the publication.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
The Empty Chair in Antitrust Conspiracy Cases
Webinar
Antitrust
USC Gould/Analysis Group Global Competition Law Thought Leadership Conference
Speaking Engagement
Antitrust
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
GCR Live: Europe 2026
Speaking Engagement
Antitrust
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
From Listings to Litigation: Zillow and Redfin Face Continued Litigation with the FTC and States
Axinn Viewpoints
Antitrust
Informa CompLaw Antitrust West Coast Conference 2026
Speaking Engagement
Antitrust
ABA 2026 International Law Section Annual Conference
Speaking Engagement
Antitrust
No Games in Merger Review: DOJ Signals Discipline and Continuity
Axinn Viewpoints
Antitrust
I litigated the JetBlue-Spirit merger. A few thoughts on the future of antitrust in the airline industry
Byline Articles
Antitrust